Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Mar 1;6(3):a026104.
doi: 10.1101/cshperspect.a026104.

The Cell-Cycle Arrest and Apoptotic Functions of p53 in Tumor Initiation and Progression

Affiliations
Review

The Cell-Cycle Arrest and Apoptotic Functions of p53 in Tumor Initiation and Progression

Jiandong Chen. Cold Spring Harb Perspect Med. .

Abstract

P53 is a transcription factor highly inducible by many stress signals such as DNA damage, oncogene activation, and nutrient deprivation. Cell-cycle arrest and apoptosis are the most prominent outcomes of p53 activation. Many studies showed that p53 cell-cycle and apoptosis functions are important for preventing tumor development. p53 also regulates many cellular processes including metabolism, antioxidant response, and DNA repair. Emerging evidence suggests that these noncanonical p53 activities may also have potent antitumor effects within certain context. This review focuses on the cell-cycle arrest and apoptosis functions of p53, their roles in tumor suppression, and the regulation of cell fate decision after p53 activation.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
p53 induces different target genes to block different stages of tumor development. Metabolic/antioxidant/DNA repair genes reduce the chance of spontaneous tumor initiation by maintaining homeostasis, reducing mutation rates, blocking epigenetic changes, and promoting DNA damage repair. When tumors pass the initiation step, tumor progression is blocked by apoptosis/cell-cycle arrest/senescence activities.

Similar articles

Cited by

References

    1. Barboza JA, Liu G, Ju Z, El-Naggar AK, Lozano G. 2006. p21 delays tumor onset by preservation of chromosomal stability. Proc Natl Acad Sci 103: 19842–19847. - PMC - PubMed
    1. Beausejour CM, Krtolica A, Galimi F, Narita M, Lowe SW, Yaswen P, Campisi J. 2003. Reversal of human cellular senescence: Roles of the p53 and p16 pathways. EMBO J 22: 4212–4222. - PMC - PubMed
    1. Bergamaschi D, Samuels Y, O’Neil NJ, Trigiante G, Crook T, Hsieh JK, O’Connor DJ, Zhong S, Campargue I, Tomlinson ML, et al. 2003. iASPP oncoprotein is a key inhibitor of p53 conserved from worm to human. Nat Genet 33: 162–167. - PubMed
    1. Bergamaschi D, Samuels Y, Sullivan A, Zvelebil M, Breyssens H, Bisso A, Del Sal G, Syed N, Smith P, Gasco M, et al. 2006. iASPP preferentially binds p53 proline-rich region and modulates apoptotic function of codon 72-polymorphic p53. Nat Genet 38: 1133–1141. - PubMed
    1. Bonasio R, Tu S, Reinberg D. 2010. Molecular signals of epigenetic states. Science 330: 612–616. - PMC - PubMed

Publication types

Substances